Transforming Cancer Treatment


OX1001 (Saq-NO) is an analog of an approved HIV protease inhibitor, Saquinavir. OX1001 induces apoptosis in prostate cancer and melanoma cells a.o. and synergizes in vitro with commonly used chemotherapeutic agents

OX1001 is a potent inhibitor of tumor growth in mouse models of prostate cancer and melanoma

For more information, please see the following scientific papers:

Maksimovic-Ivanic et al. Mol Cancer Therapeut 2009:8;1169

Rothweiler et al. Neoplasia 2010:12;1023

Mijatovic et al. J Cell Physiol 2011:226;1803

Donia et al. Cell Cycle 2011:10;492

Canducci et al. Antiviral Res 2011:91;292